MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH Has $9.22 Million Position in The Clorox Company (NYSE:CLX)

MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH lifted its stake in shares of The Clorox Company (NYSE:CLX) by 819.2% in the first quarter, according to the company in its most recent filing with the SEC. The fund owned 60,190 shares of the company’s stock after buying an additional 53,642 shares during the quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH’s holdings in Clorox were worth $9,216,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of CLX. Choreo LLC lifted its position in Clorox by 12.8% during the fourth quarter. Choreo LLC now owns 5,741 shares of the company’s stock worth $819,000 after acquiring an additional 652 shares during the last quarter. abrdn plc increased its stake in shares of Clorox by 20.1% during the fourth quarter. abrdn plc now owns 198,250 shares of the company’s stock worth $28,268,000 after purchasing an additional 33,135 shares during the period. Savoir Faire Capital Management L.P. lifted its holdings in Clorox by 61.8% during the 4th quarter. Savoir Faire Capital Management L.P. now owns 65,192 shares of the company’s stock worth $9,296,000 after purchasing an additional 24,897 shares during the last quarter. Game Plan Financial Advisors LLC bought a new stake in Clorox in the 1st quarter valued at $1,025,000. Finally, Banque Cantonale Vaudoise grew its holdings in Clorox by 78.2% in the 1st quarter. Banque Cantonale Vaudoise now owns 29,335 shares of the company’s stock valued at $4,492,000 after buying an additional 12,872 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Analyst Ratings Changes

CLX has been the subject of a number of recent research reports. Argus raised shares of Clorox to a “hold” rating in a research report on Tuesday, June 4th. Evercore ISI decreased their target price on shares of Clorox from $145.00 to $142.00 and set an “underperform” rating on the stock in a research report on Wednesday, May 1st. Deutsche Bank Aktiengesellschaft dropped their price target on shares of Clorox from $155.00 to $151.00 and set a “hold” rating for the company in a research report on Wednesday, April 17th. Citigroup lowered their price objective on Clorox from $155.00 to $150.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 1st. Finally, BNP Paribas started coverage on Clorox in a research report on Monday, June 24th. They set an “underperform” rating and a $130.00 target price for the company. Five analysts have rated the stock with a sell rating and fourteen have given a hold rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $145.33.

Clorox Price Performance

NYSE:CLX traded down $0.69 on Tuesday, hitting $133.55. The company had a trading volume of 899,720 shares, compared to its average volume of 1,259,926. The firm has a 50 day moving average of $136.74 and a two-hundred day moving average of $143.73. The stock has a market capitalization of $16.59 billion, a price-to-earnings ratio of 69.20, a PEG ratio of 2.19 and a beta of 0.39. The Clorox Company has a 52 week low of $114.68 and a 52 week high of $169.14. The company has a current ratio of 0.90, a quick ratio of 0.53 and a debt-to-equity ratio of 9.73.

Clorox (NYSE:CLX) last released its quarterly earnings data on Tuesday, April 30th. The company reported $1.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.33 by $0.38. The company had revenue of $1.81 billion during the quarter, compared to the consensus estimate of $1.87 billion. Clorox had a return on equity of 302.49% and a net margin of 3.33%. The firm’s revenue was down 5.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.51 earnings per share. On average, research analysts anticipate that The Clorox Company will post 5.91 earnings per share for the current year.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.